| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 130.118 | 170.328 | 193.714 | 221.427 | 260.438 | 290.160 | 306.299 | 328.328 |
| Total Income - EUR | - | 0 | 130.118 | 170.328 | 193.714 | 221.427 | 260.438 | 290.160 | 306.299 | 328.328 |
| Total Expenses - EUR | - | 0 | 12.507 | 18.049 | 21.751 | 21.313 | 19.712 | 31.329 | 37.377 | 32.402 |
| Gross Profit/Loss - EUR | - | 0 | 117.611 | 152.280 | 171.963 | 200.113 | 240.726 | 258.832 | 268.922 | 295.926 |
| Net Profit/Loss - EUR | - | 0 | 116.691 | 150.576 | 170.025 | 197.993 | 238.434 | 255.988 | 265.920 | 286.273 |
| Employees | - | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Medicant Gastroderm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 96 | 94 | 1.481 | 8.741 | 7.525 | 5.747 | 4.478 | 5.514 | 3.890 |
| Current Assets | - | 60 | 119.106 | 156.642 | 30.766 | 192.544 | 238.860 | 253.285 | 267.118 | 293.655 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 205 | 0 | 0 | 0 |
| Receivables | - | 0 | 113.707 | 131.966 | 7.631 | 130.949 | 188.604 | 233.839 | 253.924 | 243.795 |
| Cash | - | 60 | 5.399 | 24.675 | 23.135 | 61.595 | 50.050 | 19.446 | 13.194 | 49.860 |
| Shareholders Funds | - | 44 | 116.735 | 150.619 | 42 | 198.035 | 237.463 | 256.029 | 265.961 | 286.313 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 111 | 2.465 | 7.504 | 39.465 | 2.034 | 7.143 | 1.735 | 6.672 | 11.231 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medicant Gastroderm S.r.l.